amlo
actavis h.f. reykjavikurvegur 78, 220 hafnarfjörður, iceland - amlodipine - tablet - amlodipine 10 mg - calcium channel blockers
amlo
actavis h.f. reykjavikurvegur 78, 220 hafnarfjörður, iceland - amlodipine - tablet - amlodipine 5 mg - calcium channel blockers
amlodipine
wpr healthcare limited - amlodipine as amlodipine besilate - tablets - 5 milligram - amlodipine - calcium channel blockers, selective calcium channel blockers with mainly vascular effects - hypertension. chronic stable angina pectoris. vasospastic (prinzmetal’s) angina
amlodipine
wpr healthcare limited - amlodipine as amlodipine besilate - tablets - 10 milligram - amlodipine - calcium channel blockers, selective calcium channel blockers with mainly vascular effects - hypertension. chronic stable angina pectoris. vasospastic (prinzmetal’s) angina
apo-amlodipine amlodipine 10 mg (as besilate) tablet bottle
arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 14 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; magnesium stearate; maize starch; lactose monohydrate - hypertension - apo-amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of apo-amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor. angina - apo-amlodipine is indicated for the first line treatment of chronic stable angina. apo-amlodipine may be used alone, as monotherapy or in combination with other antianginal drugs.
apo-amlodipine amlodipine 5 mg (as besilate) tablet bottle
arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 7 mg - tablet, uncoated - excipient ingredients: maize starch; magnesium stearate; microcrystalline cellulose; lactose monohydrate - hypertension - apo-amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of apo-amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor. angina - apo-amlodipine is indicated for the first line treatment of chronic stable angina. apo-amlodipine may be used alone, as monotherapy or in combination with other antianginal drugs.
apo-amlodipine
apotex nz ltd - amlodipine besilate 14mg equivalent to to 10 mg amlodipine; - tablet - 10 mg - active: amlodipine besilate 14mg equivalent to to 10 mg amlodipine excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose - apo-amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent, or an angiotensin-converting enzyme inhibitor. apo-amlodipine is indicated for the first line treatment of myocardial ischaemia, whether due to fixed obstruction (stable angina) and/or vasospasm/vasoconstriction (prinzmetal's or variant angina) of coronary vasculature. amlodipine may be used where the clinical presentation suggests a possible vasospastic/vasoconstrictive component but where vasospasm/vasoconstriction has not been confirmed. apo-amlodipine may be used alone as monotherapy, or in combination with other antianginal drugs in patients with angina that is refractory to nitrates and/or beta blockers.
apo-amlodipine
apotex nz ltd - amlodipine besilate 3.5mg equivalent to 2.5 mg amlodipine; - tablet - 2.5 mg - active: amlodipine besilate 3.5mg equivalent to 2.5 mg amlodipine excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose - apo-amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent, or an angiotensin-converting enzyme inhibitor. apo-amlodipine is indicated for the first line treatment of myocardial ischaemia, whether due to fixed obstruction (stable angina) and/or vasospasm/vasoconstriction (prinzmetal's or variant angina) of coronary vasculature. amlodipine may be used where the clinical presentation suggests a possible vasospastic/vasoconstrictive component but where vasospasm/vasoconstriction has not been confirmed. apo-amlodipine may be used alone as monotherapy, or in combination with other antianginal drugs in patients with angina that is refractory to nitrates and/or beta blockers.
apo-amlodipine
apotex nz ltd - amlodipine besilate 7mg equivalent to to 5 mg amlodipine; - tablet - 5 mg - active: amlodipine besilate 7mg equivalent to to 5 mg amlodipine excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose - apo-amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent, or an angiotensin-converting enzyme inhibitor. apo-amlodipine is indicated for the first line treatment of myocardial ischaemia, whether due to fixed obstruction (stable angina) and/or vasospasm/vasoconstriction (prinzmetal's or variant angina) of coronary vasculature. amlodipine may be used where the clinical presentation suggests a possible vasospastic/vasoconstrictive component but where vasospasm/vasoconstriction has not been confirmed. apo-amlodipine may be used alone as monotherapy, or in combination with other antianginal drugs in patients with angina that is refractory to nitrates and/or beta blockers.
auro-amlodipine 10
aurobindo pharma nz limited - amlodipine besilate 13.8696mg equivalent to amlodipine 10 mg - tablet - 10 mg - active: amlodipine besilate 13.8696mg equivalent to amlodipine 10 mg excipient: calcium hydrogen phosphate microcrystalline cellulose ph101 magnesium stearate microcrystalline cellulose sodium starch glycolate - auro-amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of auro-amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent, or an angiotensin-converting enzyme inhibitor.